Ładuje się......
Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
AIM: To evaluate which patients with hepatocellular carcinoma (HCC) are most likely to respond to thalidomide treatment. METHODS: From July 2002 to July 2004, patients with HCC who received thalidomide treatment, were enrolled. We extracted relevant data from the patients’ medical records, including...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Baishideng Publishing Group Co., Limited
2006
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4087338/ https://ncbi.nlm.nih.gov/pubmed/17109516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i43.6955 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|